Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of EMLA cream before non-coring needle insertion in patients with totally implantable access ports
ChiCTR2400093911Phase 4Completed
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Dec 2024
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine + prilocaine in pain (2 arms), sponsored by Sun Yat-sen University Cancer Center. Primary endpoint: Complication. Started Dec 2024; status: completed.
02
Drugs
lidocaine + prilocaine
03
Conditions
pain
Beyond the preview
Go deeper on ChiCTR2400093911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093911.